Neuren Pharmaceuticals | NEU - Operating Profit


Neuren Pharmaceuticals reported AUD17.01M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organon & Co USD 266M 49M Mar/2026
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026